Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Spain / NCT06858345
Recruiting Observational

Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy

NCT06858345 · tracked via the Priya Life Science Spain tracker
Sponsor
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Phase
Observational
Started
2025-01-01
Last updated
2025-03-05

Condition(s) studied

Preeclampsia

Study summary

The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to blood volume, vascular resistance, cardiac output, etc.). The goal is to personalize therapy to more effectively treat hypertensive states of pregnancy.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age greater than or equal to 18 years * Women with singleton and twin pregnancies complicated by hypertensive states of pregnancy. Exclusion Criteria: * Minors under 18 years of age. * Women with mental disabilities. * Major congenital fetal anomaly.

Primary outcome measure(s)

  • Prolongation of at least one week of gestation in pregnancy complicated by hypertensive state of pregnancy with antihypertensive therapy guided by hemodynamic phenotypes — Up to 40 weeks
    Number of weeks of pregnancy

Trial sites (1)

FacilityCityRegionStatus
HCUVA El Palmar Murcia Recruiting

More Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia trials in Spain

Standardized Resistance Training Program and Assessment System for Prostate Cancer Patients Receiving Androgen Deprivation Therapy ISPoRT-PCa-ADT Study Protocol for a Randomized Controlled Trial. SPORT-MU Starting soon
Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer) Recruiting
Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic Version Recruiting
Efficacy of Self-titration of Ventilation in Overlap Syndrome (chronic Obstructive Pulmonar Disease + Sleep Apnea Syndrome ) with Dynamic Hyperinflation. EDIN-IDIN. Starting soon
First Trimester Prediction of Gestational Diabetes Mellitus by Continuous Glucose Monitoring. Recruiting

Other trials for the same condition

Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome Recruiting
NOPE37: Angiogenic Factors for Managing Term Preeclampsia Recruiting
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term. Recruiting
Optimizing the Use of Aspirin for the Prevention of Preeclampsia Starting soon
Molecular Study of the Maternal-fetal Interface in Preeclampsia. Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06858345 on ClinicalTrials.gov ↗ ← All trials in Spain